GRAUPNER GERHART has a total of 13 patent applications. Its first patent ever was published in 2000. It filed its patents most often in United States, Australia and Canada. Its main competitors in its focus markets pharmaceuticals, measurement and machines are NEURALTUS PHARMACEUTICALS INC, CYTOCHROMA INC and CT MOLECULAR MED & IMMUNOLOGY.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 4 | |
#2 | Australia | 3 | |
#3 | Canada | 2 | |
#4 | EPO (European Patent Office) | 2 | |
#5 | WIPO (World Intellectual Property Organization) | 2 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Measurement | |
#3 | Machines | |
#4 | Biotechnology | |
#5 | Micro-structure and nano-technology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Analysing materials | |
#4 | Unspecified technologies | |
#5 | Peptides | |
#6 | Nanostructure applications |
# | Name | Total Patents |
---|---|---|
#1 | Graupner Gerhart | 13 |
Publication | Filing date | Title |
---|---|---|
US2012172283A1 | Methods and compositions for targeted drug delivery | |
AU2005203401A1 | Targeting bioactive materials via somatostatin receptors | |
US7605185B2 | Treatment of arrhythmia by retinoids affecting signal transduction | |
US7122172B1 | Methods and compositions for targeted drug delivery | |
AU3082901A | Modulation of signal transduction | |
WO0053236A2 | Methods and compositions for targeted drug delivery |